- Stocks
- Healthcare
- NYSE: MDT

Price (delayed)

$128.54

Market cap

$172.75B

P/E Ratio

47.96

Dividend/share

$2.37

EPS

$2.68

Enterprise value

$195.54B

Medtronic's quick ratio has increased by 27% YoY and by 21% from the previous quarter

MDT's gross profit is up by 10% since the previous quarter

The net income has contracted by 25% YoY but it has grown by 25% from the previous quarter

The EPS rose by 25% since the previous quarter but it has declined by 25% year-on-year

The price to earnings (P/E) is 43% higher than the 5-year quarterly average of 33.6 and 14% higher than the last 4 quarters average of 42.1

What are the main financial stats of MDT

Market
Valuations
Earnings

Shares outstanding

1.34B

Market cap

$172.75B

Enterprise value

$195.54B

Price to earnings (P/E)

47.96

Price to book (P/B)

3.37

Price to sales (P/S)

5.74

EV/EBIT

40.77

EV/EBITDA

26.08

EV/Sales

6.49

Revenue

$30.12B

EBIT

$4.8B

EBITDA

$7.5B

Free cash flow

$4.89B

Per share
Balance sheet
Liquidity

EPS

$2.68

Free cash flow per share

$3.63

Book value per share

$38.15

Revenue per share

$22.39

TBVPS

$24.82

Total assets

$93.08B

Total liabilities

$41.48B

Debt

$26.39B

Equity

$51.43B

Working capital

$14.04B

Debt to equity

0.51

Current ratio

2.65

Quick ratio

1.91

Net debt/EBITDA

3.04

Margins
Efficiency
Dividend

EBITDA margin

24.9%

Gross margin

65.2%

Net margin

12%

Operating margin

14.9%

Return on assets

3.8%

Return on equity

7.1%

Return on invested capital

10.2%

Return on capital employed

5.7%

Return on sales

15.9%

Dividend yield

1.84%

DPS

$2.37

Payout ratio

88.4%

How has the Medtronic stock price performed over time

Intraday

1.13%

1 week

2.18%

1 month

2.43%

1 year

33.11%

YTD

9.73%

QTD

3.55%

How have Medtronic's revenue and profit performed over time

Revenue

$30.12B

Gross profit

$19.63B

Operating income

$4.48B

Net income

$3.61B

Gross margin

65.2%

Net margin

12%

The operating income has increased by 40% QoQ but it has decreased by 6% YoY

The operating margin has increased by 31% since the previous quarter but it has declined by 10% year-on-year

MDT's net margin is down by 28% year-on-year but it is up by 15% since the previous quarter

The net income has contracted by 25% YoY but it has grown by 25% from the previous quarter

What is Medtronic's growth rate over time

What is Medtronic stock price valuation

P/E

47.96

P/B

3.37

P/S

5.74

EV/EBIT

40.77

EV/EBITDA

26.08

EV/Sales

6.49

The price to earnings (P/E) is 43% higher than the 5-year quarterly average of 33.6 and 14% higher than the last 4 quarters average of 42.1

The EPS rose by 25% since the previous quarter but it has declined by 25% year-on-year

MDT's P/S is 33% higher than its 5-year quarterly average of 4.3 and 10% higher than its last 4 quarters average of 5.2

Medtronic's revenue has increased by 8% from the previous quarter and by 4.2% YoY

How efficient is Medtronic business performance

The company's return on invested capital rose by 34% QoQ but it fell by 12% YoY

The return on sales rose by 28% since the previous quarter but it has declined by 10% year-on-year

MDT's return on assets is down by 27% year-on-year but it is up by 23% since the previous quarter

Medtronic's return on equity has increased by 25% QoQ but it has decreased by 24% YoY

What is MDT's dividend history

DPS

$2.37

Dividend yield

1.84%

Payout ratio

88.4%

Recent dividends

How did Medtronic financials performed over time

The total assets is 124% greater than the total liabilities

Medtronic's quick ratio has increased by 27% YoY and by 21% from the previous quarter

The company's current ratio rose by 26% QoQ and by 24% YoY

MDT's debt is 49% smaller than its equity

Medtronic's debt to equity has decreased by 15% from the previous quarter but it has increased by 4.1% YoY

MDT's debt is down by 13% since the previous quarter but it is up by 6% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.